Vimarsana
Biggest News Aggregation in the World

Dotted Yeti News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dotted Yeti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dotted Yeti Today - Breaking & Trending Today

Boosters slow antibody waning but hit a ceiling: Long-term COVID study reveals limits of immunity - Vimarsana News

Boosters slow antibody waning but hit a ceiling: Long-term COVID study reveals limits of immunity

The study tracks the long-term kinetics of antibody responses to SARS-CoV-2 after vaccination and infections in New York healthcare workers from 2020 to 2023. It reveals that antibody waning is slower after booster shots, but there's an upper limit to antibody levels, which gradually lowers with repeated SARS-CoV-2 exposures and vaccinations.

CDC reports on its Mpox response - Vimarsana News

CDC reports on its Mpox response

Research paper provides an overview of the U.S. monkeypox outbreak, highlighting the rapid response, vaccination efforts, and racial disparities in cases. Ongoing surveillance, vaccination, and communication are emphasized as crucial for future prevention.

JYNNEOS vaccine shows strong effectiveness against Mpox in New York outbreak - Vimarsana News

JYNNEOS vaccine shows strong effectiveness against Mpox in New York outbreak

In the recent Morbidity and Mortality Weekly Report (MMWR) published by the Centers for Disease Control and Prevention (CDC), researchers reported on JYNNEOS vaccine effectiveness (VE) against Mpox infections among New York (NY) residents in 2022.

HIV status does not affect Tecovirimat treatment outcomes for Mpox virus infection - Vimarsana News

HIV status does not affect Tecovirimat treatment outcomes for Mpox virus infection

A retrospective cohort study comparing the clinical presentation and treatment outcomes of people with HIV and those without HIV who were treated with tecovirimat for confirmed mpox virus infection. The study found that HIV status did not seem to affect treatment outcomes.

Efficacy of a single dose of MVA-BN smallpox vaccine against Mpox - Vimarsana News

Efficacy of a single dose of MVA-BN smallpox vaccine against Mpox

A recent The Lancet Infectious Disease study focussed on estimating the effectiveness of a single dose of MVA-BN against Mpox in England. This observational study was conducted following the large-scale vaccination program that immunized the GBMSM group with the MVA-BN vaccine.